Compound ID | 672
Synonym(s): LBM415
Class: Peptide deformylase inhibitor
| Spectrum of activity: | Gram-negative |
| Details of activity: | Growth inhibitor; active against CAP |
| Institute where first reported: | Vernalis, UK; Novartis, Switzerland; Pfizer, US |
| Year first mentioned: | 2000 |
| Highest developmental phase: | Phase 1 |
| Development status: | Inactive |
| Reason Dropped: | Toxicity issues (JS) and possible resistance issues |
| Chemical structure(s): | |||||||||||
|
|